PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Consultant Physician & Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra.\', \'Director, Pulmonary Medicine, Fortis Hospital, Kolkata, West Bengal.\', \'Director, Metro Centre for Respiratory Diseases, Noida, Uttar Pradesh.\', \'Director, Critical Care, Nanavati Hospital, Mumbai, Maharashtra.\', \'Consultant ID Specialist, Columbia Asia Hospital, Pune, Maharashtra.\', \'Manager Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, Maharashtra; Corresponding Author.\', \'Senior Manager,Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, Maharashtra.\', \'Team Lead,Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, Maharashtra.\', \'Senior Vice President, Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, Maharashtra.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • The Journal of the Association of Physicians of India
is ?:pmid of
?:pmid
?:pmid
  • 35057588
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.204
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Real-world Experience with Favipiravir for Treatment of COVID-19 among Indian Healthcare Professionals.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35057588>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35057588>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all